Evidence map›Paper›PMID 40810646›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Confocal Absorbance-Activated Droplet Sorting (cAADS) for Enzyme Engineering.

Abdi Mirgissa Kaba, Sébastien Gounel, Thomas Beneyton, Lionel Buisson, Jean-Christophe Baret, Nicolas Mano

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Confocal Absorbance-Activated Droplet Sorting (cAADS) for Enzyme Engineering.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdi Mirgissa KabaCentre de Recherche Paul Pascal (CRPP), CNRS UMR 5031, Univ. Bordeaux, 115 Avenue du Docteur Schweitzer, Pessac, 33600, France.ORCID https://orcid.org/0000-0002-3424-0614
Sébastien GounelCentre de Recherche Paul Pascal (CRPP), CNRS UMR 5031, Univ. Bordeaux, 115 Avenue du Docteur Schweitzer, Pessac, 33600, France.ORCID https://orcid.org/0000-0002-7602-9657
Thomas BeneytonCentre de Recherche Paul Pascal (CRPP), CNRS UMR 5031, Univ. Bordeaux, 115 Avenue du Docteur Schweitzer, Pessac, 33600, France.ORCID https://orcid.org/0000-0003-2322-4886
Lionel BuissonCentre de Recherche Paul Pascal (CRPP), CNRS UMR 5031, Univ. Bordeaux, 115 Avenue du Docteur Schweitzer, Pessac, 33600, France.ORCID https://orcid.org/0000-0003-1555-6880
Jean-Christophe BaretCentre de Recherche Paul Pascal (CRPP), CNRS UMR 5031, Univ. Bordeaux, 115 Avenue du Docteur Schweitzer, Pessac, 33600, France.ORCID https://orcid.org/0000-0003-2048-8317
Nicolas ManoCentre de Recherche Paul Pascal (CRPP), CNRS UMR 5031, Univ. Bordeaux, 115 Avenue du Docteur Schweitzer, Pessac, 33600, France.ORCID https://orcid.org/0000-0001-7084-9323

Funding

Agence Nationale de la Recherche 24-CE07-1874-02French National Research Agency (ANR) ANR-21-CE19-0015-04
6 · The paper itself

Abstract

Directed evolution relies on iterative cycles of variant generation, screening, and selection to identify enzyme variants with improved activities. Droplet-based microfluidics accelerates this process by enabling rapid screening of enzyme variants in water-in-oil emulsions acting as picoliter-scale microcompartments. In fluorescence-activated droplet sorting (FADS), single E.coli cells are screened using a fluorogenic substrate at high throughput (≈2 kHz). However, fluorogenic assays for enzymatic systems are limited, while absorbance-based detection assays represent a larger spectrum. At the micron scale, light absorption is weak, and scattering induced by droplet interfacial curvature further decreases detection sensitivity. Measurements are therefore performed at a cost of increasing droplet sizes or acquisition times, which limits throughput to <1 kHz. Here, this challenge is addressed with a confocal Absorbance-Activated Droplet Sorting (cAADS) system. The platform achieves sensitive absorbance measurements at ultrahigh throughput (5.4 kHz) from droplets as small as 10 pL, and sorting of 50 pL droplets at frequencies up to 2.6 kHz. The cAADS methodology is demonstrated by enrichment of active Bilirubin Oxidase (BOD) variants, with a sorting efficiency of 99%. Its versatility and potential for absorbance-based microfluidic screening in enzyme engineering are also demonstrated using a different enzyme: Glucose Oxidase.

Indexed as

Directed Molecular EvolutionMicrofluidicsProtein EngineeringEscherichia coliabsorbance‐activated droplet screeningbilirubin oxidasedirected evolutiondroplet‐based microfluidicshigh‐throughput screening

Identifiers

PMID40810646
PMCPMC12591201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.